JPMorgan Chase & Co’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $537M | Buy |
|
|||||
|
2025
Q1 | $283M | Sell |
|
|||||
|
2024
Q4 | $338M | Sell |
|
|||||
|
2024
Q3 | $372M | Sell |
|
|||||
|
2024
Q2 | $761M | Buy |
|
|||||
|
2024
Q1 | $790M | Buy |
|
|||||
|
2023
Q4 | $701M | Buy |
|
|||||
|
2023
Q3 | $505M | Sell |
|
|||||
|
2023
Q2 | $1.63B | Buy |
|
|||||
|
2023
Q1 | $1.25B | Buy |
|
|||||
|
2022
Q4 | $1.21B | Buy |
|
|||||
|
2022
Q3 | $825M | Sell |
|
|||||
|
2022
Q2 | $774M | Sell |
|
|||||
|
2022
Q1 | $1.45B | Sell |
|
|||||
|
2021
Q4 | $1.57B | Sell |
|
|||||
|
2021
Q3 | $1.64B | Sell |
|
|||||
|
2021
Q2 | $1.6B | Buy |
|
|||||
|
2021
Q1 | $1.03B | Sell |
|
|||||
|
2020
Q4 | $1.13B | Sell |
|
|||||
|
2020
Q3 | $1.24B | Buy |
|
|||||
|
2020
Q2 | $1.23B | Sell |
|
|||||
|
2020
Q1 | $935M | Sell |
|
|||||
|
2019
Q4 | $789M | Sell |
|
|||||
|
2019
Q3 | $538M | Sell |
|
|||||
|
2019
Q2 | $627M | Sell |
|
|||||
|
2019
Q1 | $543M | Sell |
|
|||||
|
2018
Q4 | $626M | Buy |
|
|||||
|
2018
Q3 | $487M | Buy |
|
|||||
|
2018
Q2 | $274M | Buy |
|
|||||
|
2018
Q1 | $192M | Buy |
|
|||||
|
2017
Q4 | $136M | Buy |
|
|||||
|
2017
Q3 | $107M | Buy |
|
|||||
|
2017
Q2 | $81.9M | Buy |
|
|||||
|
2017
Q1 | $80.9M | Buy |
|
|||||
|
2016
Q4 | $1.14M | Buy |
|
|||||
|
2016
Q3 | $1.07M | Sell |
|
|||||
|
2016
Q2 | $8.32M | Buy |
|
|||||
|
2016
Q1 | $631K | Sell |
|
|||||
|
2015
Q4 | $1.62M | Buy |
|
|||||
|
2015
Q3 | $362K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $4.14M | Buy |
|
|||||
|
2014
Q4 | $302K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $207K | Sell |
|
|||||
|
2014
Q1 | $641K | Sell |
|
|||||
|
2013
Q4 | $676K | Sell |
|
|||||
|
2013
Q3 | $956K | Sell |
|
|||||
|
2013
Q2 | $978K | Buy |
|